Arkema is engaged in the global chemical industry which is a processing industry based on the transformation in one or several stages of raw materials (oil derivatives, gas, minerals, natural products) into more or less complex chemical products, or into plastics obtained by polymerization. In addition, Co. manufactures a wide range of products for other major industries: construction, packaging, chemicals, automotive, electronics, food manufacturing, pharmaceuticals, etc. Co. operates in this industrial context with a business portfolio focused on three segments: High Performance Materials, Industrial Specialties, and Coating Solutions.
  • TickerAKE
  • ISINFR0010313833
  • ExchangeEuronext Paris
  • SectorChemicals
  • CountryFrance

ARKEMA with less fundamental stars is reduced to Neutral

ARKEMA (FR), a company active in the Commodity Chemicals industry, loses a star(s) at the fundamental level and sees its general evaluation downgraded. The independent financial analyst theScreener just removed a fundamental star(s) for a 2 over 4-star rating. As such, market behaviour remains unchanged and is evaluated as moderately risky. theScreener believes that the loss of a star(s) merits downgrade to the general evaluation of the title, which passes to Neutral. As of the analysis date October 6, 2020, the closing price was EUR 90.96 and its expected value was estimated at EUR 92.82.

Jérôme VINERIER

Short term view - ARKEMA : Falling prices.

The background trend is clearly bearish. Prices are falling again, but the movement has become hesitant. The next support is at €87.81. The background trend would be questioned should prices rise above €99.54.

Jérôme VINERIER

Analyse court terme - ARKEMA : Les prix baissent.

La tendance de fond est clairement orientée à la baisse. Les prix baissent à nouveau, mais le mouvement est devenu hésitant. Le prochain support est à 87,81 €. La tendance de fond serait remise en cause en cas de franchissement de 99,54 €.

Jérôme VINERIER

Analyse court terme - ARKEMA : La tendance de fond est clairement orientée à la baisse.

La tendance de fond est clairement orientée à la baisse. Le mouvement se poursuit. Le prochain objectif est à 87,81 €, puis 84,28 €. Le franchissement de 99,54 € remettrait en cause la suite de la baisse.

Jérôme VINERIER

Short term view - ARKEMA : The background trend is clearly bearish.

The background trend is clearly bearish. The movement goes on. The next target is at €87.81, then €84.28. Passing €99.54 would question the continuation of the fall.

Jérôme VINERIER

Analyse moyen terme - ARKEMA : La tendance est incertaine.

La tendance est incertaine. Les cours baissent, et il y a une possibilité d'accélération baissière. Une nouvelle tendance baissière tente de démarrer.

Emmanuel Matot

Arkema : Road show feedback: COVID strengthens the transformation strategy

>Main subjects mentioned: business trends, cost savings, M&A, etc. - On Monday we organised a virtual road show with Thierry le Hénaff, Arkema’s CEO, and Marie1eJosé Donsion, the CFO. Where business is concerned, visibility is presented as poor, which explains why the group has not given any guidance for 2020 (difficult to have convictions in such an exceptional health/economic context). July and August showed trends similar to June (sales = -10%), which was an improve...

Emmanuel Matot

Arkema : Feedback roadshow : le COVID renforce la stratégie de mutation

>Principaux sujets évoqués : activité, économies, M&A… - Nous avons organisé mardi un roadshow virtuel avec Thierry le Hénaff et Marie-José Donsion, respectivement CEO et CFO d’Arkema. S’agissant de l’activité, la visibilité est présentée comme faible, expliquant l’absence de guidance pour 2020 (difficile d’avoir des convictions dans un contexte sanitaire/économique aussi exceptionnel). Juillet/août se sont inscrits dans des directions ressemblant à juin (CA = -10%) q...

Emmanuel Matot

ODDO : Arkema more optimistic over recovery than Solvay

>Arkema: Q2 results less bad than expected and signs of improvement in demand - Following the release of Arkema's Q2 results on Thursday, we would note a 30% drop in EBITDA to € 286m (consensus = € 261m), hard hit by weak demand amid a severe health crisis, with volumes down 12% and transport, industry and construction particularly affected. Specialty Materials held up better (EBITDA down 23%) compared to Intermediates (EBITDA down 48%).Regarding prospects, we wo...

Emmanuel Matot

ODDO : Arkema plus optimiste sur la reprise que Solvay

>Arkema : des résultats T2 moins mauvais que prévu et des signes d’amélioration de la demande - Nous retiendrons des résultats T2 d’Arkema jeudi dernier une chute de 30% de l’EBITDA à 286 M€ (consensus = 261 M€), lourdement impacté par la faiblesse de la demande dans un contexte de grave crise sanitaire (volumes = -12% - transport, industrie et construction particulièrement touchés). Les Matériaux de Spécialités se sont montrés plus résilients (EBITDA = -23%) comparés...

Emmanuel Matot

Arkema : Q2 2020 publication reflecting the big impact of the health crisis

>Strong fall in earnings in Q2 but not as big as expected – Excellent FCF generation - Arkema has just reported its Q2 2020 results. EBITDA, the key indicator, showed a sharp fall of 30% to € 286m (after -19% in Q1) but came in ahead of expectations (consensus = € 261m). Amid a serious health crisis, volumes fell 12% (transport, industry and construction sectors particularly hard hit).All divisions posted declines (volumes, sales, EBITDA and EBITDA margin), the b...

Pierre-Antoine Bourgoin

Arkema - Assemblée Générale des actionnaires du 19 mai 2020

A la vue des récents événements relatifs au Covid-19, dont les conséquences restent encore non quantifiables, Proxinvest est favorable à l'abaissement de la distribution de dividendes initialement prévue (résolution 3). Nous n'émettons pas d'avis défavorable au renouvellement de Thierry Le Hénaff, Président Directeur Général (résolution 5). Concernant la politique de rémunération du Président Directeur Général, bien que l'augmentation de la rémunération fixe et du montant maximum de la rémunération variable annuelle fasse l'objet d'un ajournemennt, elle constitue une aggravation de la précéd...

Expert Corporate Governance Service (ECGS)

Arkema – AGM 19 May 2020

Resolution 3: In view of the recent events relating to Covid-19, which are not yet quantifiable, ECGS is in favour of lowering the dividend distribution initially planned.   Resolution 5: We do not issue an unfavourable opinion on the renewal of the term of office of Thierry Le Hénaff, Chairman and Chief Executive Officer.   Resolution 7: Concerning the compensation policy for the Chairman and Chief Executive Officer, although the increase in the fixed compensation and the maximum amount of annual variable compensation is subject to deferment, it constitutes a worsening of the previous pol...

Arkema - Assemblée générale des actionnaires du 21 mai 2019

François Enaud, administrateur référent non indépendant car en fonction depuis 13 ans, va quitter le conseil à l'issue de cette assemblée générale et sera remplacé à ce poste par un membre indépendant, Hélène Moreau-Leroy. Par ailleurs, autre point positif, le conseil est composé d'une majorité de membres libres de conflits d'intérêts potentiels. Dans ces conditions, les nominations et renouvellements proposés seront tous soutenus (résolutions 5 à 8). De nouveau, l'attention des actionnaires est attirée sur les niveaux de rémunération du Président-Directeur général qui paraissent excessives à...

Expert Corporate Governance Service (ECGS)

Arkema - AGM and EGM 21 May 2019

François Enaud, Lead Director, who is not considered as independent since he has been in office for 13 years, will leave the Board at the end of this general meeting and will be replaced by an independent member, Hélène Moreau-Leroy. Another positive point, the Board is composed by a majority of independent members. Accordingly, ECGS recommends to APPROVE all four re-elections (resolutions 5 to 8).  Once again, shareholders' attention is drawn to the excessive compensation levels of the Chairman and Chief Executive Officer, which amount to € 4.6 million in 2018. A similar amount could be allo...

Arkema – Proxinvest Corporate Governance Rating ® : D

Proxinvest Corporate Governance Rating ® helps investors integrate governance into their investment decision and identify governance risks and opportunities within their portfolio. Proxinvest Corporate Governance Rating ® Service rates European issuers through the analysis of four main themes : Ownership & Shareholder rights, Board & Committees, Audit & Process, Remuneration. Each theme is rated taking into account several comprehensive sub-categories. Our unique two-step process to achieve each rating includes a first step quantitative valuation and a second step qualitative filter...

Moody's announces completion of a periodic review of ratings of Arkema

Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Arkema. Global Credit Research- 02 Sep 2020. Frankfurt am Main, September 02, 2020-- Moody's Investors Service has completed a periodic review of the ratings of Arkema and other ratings that are associated with the same analytical unit.

Arkema - June 2020 (LTM): Peer Snapshot

Peer Snapshot:  Arkema - June 2020 (LTM) 27 August 2020 (in US millions) FYE Dec-18 FYE Dec-19 LTM Jun-20 FYE Dec-18 FYE Dec-19 LTM Jun-20 FYE Dec-18 FYE Dec-19 LTM Jun-20

Arkema - March 2020 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Arkema - December 2019 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Moody's assigns Baa3 rating to Arkema's hybrid notes; stable outlook

Rating Action: Moody's assigns Baa3 rating to Arkema's hybrid notes; stable outlook. Global Credit Research- 14 Jan 2020. Frankfurt am Main, January 14, 2020-- Moody's Investors Service today assigned a Baa3 long-term rating to the proposed issuance of E300 million Undated Deeply Subordinated Fixed Rate Resettable Notes issued by Arkema.

Alexandre Iatrides

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 09/03/2020

We are upgrading our rating on Publicis from Neutral to Buy with a target price of € 38 vs € 34 previously. The stock looks like an attractive vehicle to capitalise on an advertising catch-up over the end of the year. The valuation is still weak whilst structural risks are gradually subsiding under the effect of a more balanced relationship between advertisers and advertising agencies in the context of the pandemic. Our valuation factors in stability in the long term (+0.5% vs -0.5%) ...

Alexandre Iatrides

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 03/09/2020

Nous relevons notre recommandation sur Publicis de Neutre à Achat, avec un nouvel objectif de cours de 38 € contre 34 € précédemment. Le titre est un véhicule attractif pour profiter d’un rattrapage publicitaire sur la fin d’année. La valorisation est toujours aussi faible, alors que les risques structurels se dissipent progressivement, sous l’effet d’une relation annonceurs/agences plus équilibrée dans le contexte de la crise actuelle. Notre valorisation intègre une stabilité à long ...

Bruno Cavalier ...
  • Stephane Houri

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 08/03/2020

...

Jerôme Bodin

ODDO BHF Small & MIDCAP MORNING NEWS - 08/03/2020

...

Bruno Cavalier ...
  • Stephane Houri

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 03/08/2020

...

ARKEMA with less fundamental stars is reduced to Neutral

ARKEMA (FR), a company active in the Commodity Chemicals industry, loses a star(s) at the fundamental level and sees its general evaluation downgraded. The independent financial analyst theScreener just removed a fundamental star(s) for a 2 over 4-star rating. As such, market behaviour remains unchanged and is evaluated as moderately risky. theScreener believes that the loss of a star(s) merits downgrade to the general evaluation of the title, which passes to Neutral. As of the analysis date October 6, 2020, the closing price was EUR 90.96 and its expected value was estimated at EUR 92.82.

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the we...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch